men and women standing in front of building holding signs related to diabetes

Diabetes Dream Team

The Diabetes Research Education And Management Team (DREAM Team)

Touro California's DREAM Team — part of the College of Osteopathic Medicine — is dedicated to raising awareness, educating, and empowering all those affected by prediabetes and diabetes.

Sumera Ahmed, MD

Program Director, Diabetology Fellowship and Associate Professor, Clinical Sciences and Community Health, College of Osteopathic MedicineAssociate Medical Director, Metabolic Research Center

Biography

Sumera Ahmed, MD, is an Associate Professor at Touro University California and Program Director of Diabetology Fellowship. She is board certified in Internal Medicine and is a fellowship trained Diabetologist. She provides diabetes consultation services at Solano County FQHC serving adult patients with diabetes across the spectrum. Sumera Ahmed has coauthored publications on necessary evolution of diabetology fellowship program in the United States and developing national standards, on hospital management of diabetes and diabetes management during Ramadan fasting. She is a founding board member of American College of Diabetology.

Clinical Specialty

  • Diabetology
  • Internal Medicine

Education

  • Diabetes Fellowship - East Carolina University, Brody School of Medicine, Greenville, NC
  • MD Residency - Brookdale University Hospital and Medical Center, Brooklyn, NY
  • Medical School - Bachelor of Medicine and Bachelor of Surgery (MBBS) - Government Kilpauk Medical College, India

Research

Sub-Investigator

  • EVOLVE – Evaluation of the Fully Closed Loop Omnipod System for Safety and Efficacy in Adults with Type 2 Diabetes
  • PREMAP – Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes
  • FINE-ONE – A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease and type 1 diabetes.
  • CONFIDENCE BAY 94-8862– A Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared to either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes.
  • 18F-MC-GPGM: Efficacy and safety of LY329176 once weekly versus Insulin Glargine in patients with Type 2 diabetes and increased cardiovascular risk (SURPASS 4)

Principal Investigator

  • J2A-MC-GZGE: A Phase 2 Study of Once Daily LY3502970 Compared with Placebo and Once Weekly Dulaglutide in Participants with Type 2 Diabetes Mellitus
  • Community based diabetes and dyslipidemia screening MOBEC
  • Does hygiene education prevent genitourinary infections among patients with Type 2 diabetes on SGLT2 inhibitors?

Recent Publications

https://orcid.org/0000-0003-4014-9451

Memberships and Affiliations

  • American Diabetes Association
  • American College of Physicians

Teaching Responsibilities

  • IS-GERD course
  • OD4 GI and Endocrine labs
  • IPE Diabetes Week
  • DREAM team didactics
  • Preceptor for COM and PA clinical students on rotation with DREAM team at Solano County FQHC
  • Program Director for Diabetology Fellowship